Cara Therapeutics (CARA)
(Real Time Quote from BATS)
$0.36 USD
+0.01 (3.39%)
Updated Aug 12, 2024 10:30 AM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Cara Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -118.51 | -85.47 | -88.44 | 8.41 | -106.37 |
Depreciation/Amortization & Depletion | 1.93 | 1.93 | 2.42 | 1.17 | -0.58 |
Net Change from Assets/Liabilities | 10.28 | -12.92 | 5.26 | -29.63 | -18.84 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 14.23 | 17.73 | 20.68 | 14.56 | 16.57 |
Net Cash From Operating Activities | -92.08 | -78.73 | -60.09 | -5.49 | -109.23 |
Property & Equipment | -2.38 | -0.04 | 0.03 | -0.35 | -0.02 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 45.84 | 128.75 | -4.78 | -19.93 | -30.50 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 43.46 | 128.71 | -4.75 | -20.28 | -30.52 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 1.68 | 0.31 | 46.61 | 39.14 | 142.60 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 36.47 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 38.15 | 0.31 | 46.61 | 39.14 | 142.60 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -10.47 | 50.29 | -18.23 | 13.38 | 2.86 |
Cash at Beginning of Period | 64.15 | 13.86 | 32.09 | 18.71 | 15.85 |
Cash at End of Period | 53.68 | 64.15 | 13.86 | 32.09 | 18.71 |
Diluted Net EPS | -2.19 | -1.59 | -1.74 | 0.18 | -2.49 |
Fiscal Year End for Cara Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -30.70 | -118.51 | -86.18 | -58.14 |
Depreciation/Amortization & Depletion | NA | -0.20 | 1.93 | 1.24 | 0.82 |
Net Change from Assets/Liabilities | NA | -4.89 | 10.28 | 0.21 | -4.54 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 5.33 | 14.23 | 10.02 | 6.80 |
Net Cash From Operating Activities | NA | -30.45 | -92.08 | -74.71 | -55.06 |
Property & Equipment | NA | -0.84 | -2.38 | -0.32 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 26.79 | 45.84 | 73.99 | 50.51 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 25.95 | 43.46 | 73.67 | 50.51 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 1.68 | 1.68 | 0.56 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.69 | 36.47 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | -0.69 | 38.15 | 1.68 | 0.56 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -5.19 | -10.47 | 0.63 | -3.99 |
Cash at Beginning of Period | NA | 53.68 | 64.15 | 64.15 | 64.15 |
Cash at End of Period | NA | 48.50 | 53.68 | 64.78 | 60.16 |
Diluted Net EPS | NA | -0.56 | -0.60 | -0.52 | -0.58 |